Portfolio (Quarterly)
Guide ↗
Royalty Pharma Sub-Manager, LLC
· CIK 0002081668| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CYTK | CYTOKINETICS, INC | Healthcare | 980,392.0 | $64.6M | 37.40% | — | — | $65.91 | +15.2% |
| 2 | BCAX | ZENAS BIOPHARMA, INC. | Healthcare | 2,388,150.0 | $46.7M | 27.02% | +1.1M | +89.1% | $19.55 | +11.4% |
| 3 | BCRX | BIOCRYST PHARMACEUTICALS INC | Healthcare | 3,846,154.0 | $36.6M | 21.19% | — | — | $9.52 | -11.3% |
| 4 | — | BIOHAVEN LTD | — | 2,936,507.0 | $24.8M | 14.38% | — | — | $8.46 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%